Resource centre

Main menu

310 results

SNVs

Publication
Assessing the readiness of Oxford Nanopore sequencing for clinical genomics applications
February 11 2026
Case study
Case study: high-quality bacterial genome without the complexity
February 5 2026
Publication
Oxford Nanopore Technologies [ONT] sequencing: clinical validation in genetically heterogeneous disorders
November 3 2025
Publication
Single-workflow nanopore whole-genome sequencing with adaptive sampling for accelerated and comprehensive paediatric cancer profiling
October 3 2025
Publication
Integrating long-read nanopore sequencing for precision resolution of genomic variants in dystonia
September 30 2025
Workflow
Workflow overview: 24-hour human whole-genome sequencing
September 17 2025
Getting started guide
Getting started guide: human genomics
September 17 2025
Application note
Application note: Comprehensive genomic and epigenomic profiling with the Oxford Nanopore Hereditary Cancer Panel
September 16 2025
Workflow
Protocol overview: interaction-free whole-genome sequencing
September 15 2025
Publication
Long-read genomic and epigenomic profiling enhances timely comprehensive variant discovery in hypotonia and muscle weakness
September 9 2025
Brochure
Flyer: Hereditary Cancer Panel
September 3 2025
Case study
Case study: Oxford Nanopore sequencing at large cohort scale — new insights from the NIHR BioResource
September 1 2025
Case study
Case study: exploring the future of rapid leukaemia diagnosis with a single-platform workflow
August 7 2025
Workflow
Workflow overview: pharmacogenomics with adaptive sampling
August 5 2025
Publication
The Platinum Pedigree: a long-read benchmark for genetic variants
August 4 2025
Workflow
Workflow overview: large cohort sequencing
July 28 2025
Workflow
Workflow overview: tumour-normal sequencing
July 21 2025
Publication
High precision characterisation of RCCX rearrangements in a 21-hydroxylase deficiency Latin American cohort using Oxford Nanopore long read sequencing
July 10 2025
Publication
Screening of hidden pathogenic structural variants in PRKN
June 23 2025
Publication
Resolving RH and GYP hybrid alleles while accessing the entire blood group genome with nanopore adaptive sampling
June 11 2025

Getting started

Buy a MinION starter pack Nanopore store Sequencing service providers Channel partners

Quick links

Intellectual property Cookie policy Corporate reporting Privacy policy Terms, conditions and policies Accessibility

About Oxford Nanopore

© 2008 - 2026 Oxford Nanopore Technologies plc. All rights reserved. Registered Office: Gosling Building, Edmund Halley Road, Oxford Science Park, OX4 4DQ, UK | Registered No. 05386273 | VAT No 336942382. Oxford Nanopore Technologies, the Wheel icon, AmPORE-TB, EPI2ME, GridION, MinION, MinKNOW, PromethION, P2 Solo, and P2 are registered trademarks or the subject of trademark applications of Oxford Nanopore Technologies plc in various countries. Information contained herein may be protected by copyright, patents or patents pending of Oxford Nanopore Technologies plc. All other brands and names contained are the property of their respective owners. Oxford Nanopore Technologies products are RUO. Products labelled/branded as Oxford Nanopore Diagnostics may be RUO or may be regulated as in‐vitro diagnostic devices in some jurisdictions, please check individual product labelling.

ONT plc is a member of the producer compliance scheme run by ERP UK Ltd, who manage the submission of documentation in support of WEEE compliance for ONT plc’s manufacture and supply of Electrical and Electronic equipment in the UK.

ONT’s WEEE PRN is WEE/MM3828AA. See attached certificate for the submission period 2022.

Select Language

Focus areas

Resource Centre

Assessing the readiness of Oxford Nanopore sequencing for clinical genomics applications

Case study: high-quality bacterial genome without the complexity

Oxford Nanopore Technologies [ONT] sequencing: clinical validation in genetically heterogeneous disorders

Single-workflow nanopore whole-genome sequencing with adaptive sampling for accelerated and comprehensive paediatric cancer profiling

Integrating long-read nanopore sequencing for precision resolution of genomic variants in dystonia

Workflow overview: 24-hour human whole-genome sequencing

Getting started guide: human genomics

Application note: Comprehensive genomic and epigenomic profiling with the Oxford Nanopore Hereditary Cancer Panel

Protocol overview: interaction-free whole-genome sequencing

Long-read genomic and epigenomic profiling enhances timely comprehensive variant discovery in hypotonia and muscle weakness

Flyer: Hereditary Cancer Panel

Case study: Oxford Nanopore sequencing at large cohort scale — new insights from the NIHR BioResource

Case study: exploring the future of rapid leukaemia diagnosis with a single-platform workflow

Workflow overview: pharmacogenomics with adaptive sampling

The Platinum Pedigree: a long-read benchmark for genetic variants

Workflow overview: large cohort sequencing

Workflow overview: tumour-normal sequencing

High precision characterisation of RCCX rearrangements in a 21-hydroxylase deficiency Latin American cohort using Oxford Nanopore long read sequencing

Screening of hidden pathogenic structural variants in PRKN

Resolving RH and GYP hybrid alleles while accessing the entire blood group genome with nanopore adaptive sampling

shared.filter

Products

Research areas

Techniques